chenxu
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC (NCT07474064) | chenxu | 2026-03-26 |
Track chenxu automatically
Every clearance here is in the API, with alerts when new ones post.